FDA Announces Plans to Issue Formal Guidance on Generative AI Medical Devices
The FDA’s Digital Health Center of Excellence says it will soon publish official policy documents governing medical devices that incorporate generative AI.
Rick Abramson, who leads the agency’s Digital Health Center of Excellence, told one outlet that the FDA is drafting a regulatory framework for generative-AI-enabled medical tools. The forthcoming guidance will aim to clarify expectations for the industry. Abramson indicated that, in addition to broad policy, the agency intends to release more focused guidance on particularly complex or high-interest AI applications.
Why it matters
Clear FDA rules will shape how AI-driven medical devices are developed and approved, affecting patient safety and industry innovation.
In this story
FDAgenerative AImedical devicesregulatory guidancedigital healthpolicyRick Abramson
